GlobeNewswire

Huawei and Hexagon Geospatial Showcase Geospatial Solutions at Smart City Expo World Congress 2017

Dela

Smart Water and Smart Infrastructure Solutions Featured in Barcelona

BARCELONA, Spain, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Hexagon Geospatial is proud to announce that we will partner with Huawei to showcase Smart City solutions at Smart City Expo World Congress in Barcelona, 14-16 November.

Huawei, a leader in the Information and Communications Technology (ICT) industry, will join with Hexagon to demonstrate how Smart Cities must harness geospatial data for sustainability and to improve quality of life.

"We are excited by the opportunity to partner with Huawei to demonstrate geospatial-based Smart City solutions," said Hexagon Geospatial President Mladen Stojic. "Location-based information with real-time analytics help Smart Cities communicate with businesses and civil society and to shape smart policies. Together with Huawei, we are making that vision a reality."

At SCEWC, Hexagon Geospatial will highlight two integrated and geospatial-enabled solutions as part of the Smart Government Solution Portfolio: Water Management and Infrastructure Management.

Hexagon Geospatial Vice President of Global Strategic Partnerships, Claudio Mingrino will give a presentation on "Geospatial Integrated Solutions to Improve Cities' Management" at Huawei stand B-201, Hall 2 at the Open Speech Area, on Wednesday, November 15, from 2:30 to 3:00 pm.

Visit Huawei stand B-201 in Hall 2 for live demonstrations and to speak with our experts about Smart Government Solutions, and in particular Smart Water and Smart Infrastructure.

Smart Water

One of a city's most important pieces of critical infrastructure is its water system. With populations in cities growing, it is inevitable that water consumption will grow as well. The term "smart water" points to water and wastewater infrastructure that ensures this precious resource - and the energy used to transport it - is managed effectively.

M.App Enterprise can pinpoint specific urban problems, providing an extensive platform to deliver innovative and industry-specific solutions.

M.App Enterprise Smart Water is an online platform for geospatial infrastructure management of water and sewerage that offers:

  • Accessible content permanently updated in real time
  • Information Workflows
  • Easy and immediate access to high-tech resources
  • Independence of data from used technology

Smart Infrastructure: Public Light Management

A Smart City develops an intelligence advantage by delivering relevant geospatial data, workflows, and analytics into any device held in the hands of local government and residents interested in making the city a better place to live.

M.App Enterprise provides an extensive platform to deliver innovative and industry-specific solutions that can connect to any geospatial data source.

The Public Light Management is an asset Management tool for Smart Cities provided by Hexagon M.App Enterprise that includes:

  • Public Lights Inspection Workflow
  • Interactive Dashboard for at-a-glance views of the Power Light situation over the city
  • Mobile Alert Application

About Huawei

Huawei is a leading global information and communications technology (ICT) solutions provider. Our aim is to enrich life and improve efficiency through a better connected world, acting as a responsible corporate citizen, innovative enabler for the information society, and collaborative contributor to the industry. Driven by customer-centric innovation and open partnerships, Huawei has established an end-to-end ICT solutions portfolio that gives customers competitive advantages in telecom and enterprise networks, devices and cloud computing. Huawei's 170,000 employees worldwide are committed to creating maximum value for telecom operators, enterprises and consumers. Our innovative ICT solutions, products and services are used in more than 170 countries and regions, serving over one-third of the world's population. Founded in 1987, Huawei is a private company fully owned by its employees.

About Hexagon Geospatial

Hexagon Geospatial helps you make sense of the dynamically changing world. Known globally as a maker of leading-edge technology, we enable our customers to easily transform their data into actionable information, shortening the lifecycle from the moment of change to action. Hexagon Geospatial provides the software products and platforms to a large variety of customers through direct sales, channel partners, and Hexagon businesses. For more information, visit www.hexagongeospatial.com or contact us at marketing@hexagongeospatial.com.

Hexagon Geospatial is part of Hexagon, a leading global provider of information technologies that drive quality and productivity improvements across geospatial and industrial enterprise applications. Hexagon's solutions integrate sensors, software, domain knowledge and customer workflows into intelligent information ecosystems that deliver actionable information, automate business processes and improve productivity. They are used in a broad range of vital industries. Hexagon (Nasdaq Stockholm: HEXA B) has more than 17,000 employees in 46 countries and net sales of approximately 3.3bn USD. 
Learn more at hexagon.com.

FOR FURTHER INFORMATION

Jay Pongonis
jay.pongonis@hexagongeospatial.com

© 2017 Hexagon AB and/or its subsidiaries and affiliates. All rights reserved. Hexagon and the Hexagon logo are registered trademarks of Hexagon AB or its subsidiaries. All other trademarks or servicemarks used herein are property of their respective owners. Hexagon Geospatial believes the information in this publication is accurate as of its publication date. Such information is subject to change without notice.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hexagon Geospatial via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum